245 related articles for article (PubMed ID: 30746636)
1. The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients.
Gregorowitsch ML; Ghedri A; Young-Afat DA; Bijlsma R; Baas IO; van Schaik-van de Mheen C; Agterof MJ; Göker E; Ten Bokkel Huinink D; van den Bongard HJGD; Verkooijen HM;
Breast Cancer Res Treat; 2019 Jun; 175(2):429-441. PubMed ID: 30746636
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
3. Physical Functioning in Older Patients With Breast Cancer: A Prospective Cohort Study in the TEAM Trial.
Derks MG; de Glas NA; Bastiaannet E; de Craen AJ; Portielje JE; van de Velde CJ; van Leeuwen FE; Liefers GJ
Oncologist; 2016 Aug; 21(8):946-53. PubMed ID: 27368882
[TBL] [Abstract][Full Text] [Related]
4. Self-reported cognitive decline in Japanese patients with breast cancer treated with endocrine therapy.
Yamamoto S; Masutani E; Arao H
Breast Cancer; 2020 Jul; 27(4):670-682. PubMed ID: 32114664
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
Leinert E; Singer S; Janni W; Harbeck N; Weissenbacher T; Rack B; Augustin D; Wischnik A; Kiechle M; Ettl J; Fink V; Schwentner L; Eichler M
Clin Breast Cancer; 2017 Apr; 17(2):100-106. PubMed ID: 27884722
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in long term breast cancer survivors treated with breast conserving therapy: impact of age at therapy.
Fehlauer F; Tribius S; Mehnert A; Rades D
Breast Cancer Res Treat; 2005 Aug; 92(3):217-22. PubMed ID: 16155792
[TBL] [Abstract][Full Text] [Related]
7. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA
J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545
[TBL] [Abstract][Full Text] [Related]
8. Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis.
Ferreira AR; Di Meglio A; Pistilli B; Gbenou AS; El-Mouhebb M; Dauchy S; Charles C; Joly F; Everhard S; Lambertini M; Coutant C; Cottu P; Lerebours F; Petit T; Dalenc F; Rouanet P; Arnaud A; Martin A; Berille J; Ganz PA; Partridge AH; Delaloge S; Michiels S; Andre F; Vaz-Luis I
Ann Oncol; 2019 Nov; 30(11):1784-1795. PubMed ID: 31591636
[TBL] [Abstract][Full Text] [Related]
9. Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study.
Janelsins MC; Heckler CE; Peppone LJ; Kamen C; Mustian KM; Mohile SG; Magnuson A; Kleckner IR; Guido JJ; Young KL; Conlin AK; Weiselberg LR; Mitchell JW; Ambrosone CA; Ahles TA; Morrow GR
J Clin Oncol; 2017 Feb; 35(5):506-514. PubMed ID: 28029304
[TBL] [Abstract][Full Text] [Related]
10. A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy.
Lawrence JA; Griffin L; Balcueva EP; Groteluschen DL; Samuel TA; Lesser GJ; Naughton MJ; Case LD; Shaw EG; Rapp SR
J Cancer Surviv; 2016 Feb; 10(1):176-84. PubMed ID: 26130292
[TBL] [Abstract][Full Text] [Related]
11. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
[TBL] [Abstract][Full Text] [Related]
12. Cognitive function and discontinuation of adjuvant hormonal therapy in older breast cancer survivors: CALGB 369901 (Alliance).
Bluethmann SM; Alfano CM; Clapp JD; Luta G; Small BJ; Hurria A; Cohen HJ; Sugarman S; B Muss H; Isaacs C; Mandelblatt JS
Breast Cancer Res Treat; 2017 Oct; 165(3):677-686. PubMed ID: 28653250
[TBL] [Abstract][Full Text] [Related]
13. Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study.
Schilder CM; Seynaeve C; Linn SC; Boogerd W; Beex LV; Gundy CM; Nortier JW; van de Velde CJ; van Dam FS; Schagen SB
Psychooncology; 2012 May; 21(5):479-87. PubMed ID: 21351188
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal impact of yoga on chemotherapy-related cognitive impairment and quality of life in women with early stage breast cancer: a case series.
Galantino ML; Greene L; Daniels L; Dooley B; Muscatello L; O'Donnell L
Explore (NY); 2012; 8(2):127-35. PubMed ID: 22385567
[TBL] [Abstract][Full Text] [Related]
15. Subjective and objective cognitive functioning among patients with breast cancer: effects of chemotherapy and mood symptoms.
Hsu YH; Chen VC; Hsieh CC; Weng YP; Hsu YT; Hsiao HP; Wang WK; Chen HM; Weng JC; Wu SI; Gossop M
Breast Cancer; 2021 Jan; 28(1):236-245. PubMed ID: 33030667
[TBL] [Abstract][Full Text] [Related]
16. Severe depression more common in patients with ductal carcinoma in situ than early-stage invasive breast cancer patients.
Gregorowitsch ML; van den Bongard HJGD; Young-Afat DA; Pignol JP; van Gils CH; May AM; Verkooijen HM
Breast Cancer Res Treat; 2018 Jan; 167(1):205-213. PubMed ID: 28894982
[TBL] [Abstract][Full Text] [Related]
17. Examining the effects of adjuvant chemotherapy on cognition and the impact of any cognitive impairment on quality of life in colorectal cancer patients: study protocol.
Dwek MR; Rixon L; Simon A; Hurt C; Newman S
BMC Psychol; 2015 Nov; 3():43. PubMed ID: 26612628
[TBL] [Abstract][Full Text] [Related]
18. Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma.
Donovan KA; Small BJ; Andrykowski MA; Schmitt FA; Munster P; Jacobsen PB
Cancer; 2005 Dec; 104(11):2499-507. PubMed ID: 16247788
[TBL] [Abstract][Full Text] [Related]
19. Minimal clinically important difference (MCID) for the functional assessment of cancer therapy: cognitive function (FACT-Cog) in breast cancer patients.
Cheung YT; Foo YL; Shwe M; Tan YP; Fan G; Yong WS; Madhukumar P; Ooi WS; Chay WY; Dent RA; Ang SF; Lo SK; Yap YS; Ng R; Chan A
J Clin Epidemiol; 2014 Jul; 67(7):811-20. PubMed ID: 24656406
[TBL] [Abstract][Full Text] [Related]
20. Quality of life in patients with breast cancer before and after diagnosis: an eighteen months follow-up study.
Montazeri A; Vahdaninia M; Harirchi I; Ebrahimi M; Khaleghi F; Jarvandi S
BMC Cancer; 2008 Nov; 8():330. PubMed ID: 19014435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]